<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.jhc.org">
<title>Journal of Histochemistry and Cytochemistry recent issues</title>
<link>http://www.jhc.org</link>
<description>Journal of Histochemistry and Cytochemistry RSS feed -- recent issues</description>
<prism:publicationName>Journal of Histochemistry and Cytochemistry</prism:publicationName>
<prism:issn>0022-1554</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/8/711?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/8/723?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/8/733?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/8/745?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/8/753?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/8/765?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/8/773?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/8/785?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/7/629?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/7/639?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/7/647?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/7/659?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/7/667?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/7/677?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/7/687?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/7/697?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/531?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/539?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/551?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/561?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/569?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/579?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/587?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/597?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/605?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/6/615?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/5/425?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/5/433?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/5/443?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/5/467?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/5/477?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/5/487?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/5/495?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/5/511?rss=1" />
  <rdf:li rdf:resource="http://www.jhc.org/cgi/content/short/56/5/517?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.jhc.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.jhc.org/icons/banner/title.gif">
<title>Journal of Histochemistry and Cytochemistry</title>
<url>http://www.jhc.org/icons/banner/title.gif</url>
<link>http://www.jhc.org</link>
</image>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/8/711?rss=1">
<title><![CDATA[Histone Modifications and Nuclear Architecture: A Review]]></title>
<link>http://www.jhc.org/cgi/content/short/56/8/711?rss=1</link>
<description><![CDATA[
<p>Epigenetic modifications, such as acetylation, phosphorylation, methylation, ubiquitination, and ADP ribosylation, of the highly conserved core histones, H2A, H2B, H3, and H4, influence the genetic potential of DNA. The enormous regulatory potential of histone modification is illustrated in the vast array of epigenetic markers found throughout the genome. More than the other types of histone modification, acetylation and methylation of specific lysine residues on N-terminal histone tails are fundamental for the formation of chromatin domains, such as euchromatin, and facultative and constitutive heterochromatin. In addition, the modification of histones can cause a region of chromatin to undergo nuclear compartmentalization and, as such, specific epigenetic markers are non-randomly distributed within interphase nuclei. In this review, we summarize the principles behind epigenetic compartmentalization and the functional consequences of chromatin arrangement within interphase nuclei. <b>(J Histochem Cytochem 56:711&ndash;721, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Bartova, E., Krejci, J., Harnicarova, A., Galiova, G., Kozubek, S.]]></dc:creator>
<dc:date>2008-07-07</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.951251</dc:identifier>
<dc:title><![CDATA[Histone Modifications and Nuclear Architecture: A Review]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>721</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>711</prism:startingPage>
<prism:section>Review Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/8/723?rss=1">
<title><![CDATA[C9orf10 Protein, a Novel Protein Component of Pur{alpha}-containing mRNA-protein Particles (Pur{alpha}-mRNPs): Characterization of Developmental and Regional Expressions in the Mouse Brain]]></title>
<link>http://www.jhc.org/cgi/content/short/56/8/723?rss=1</link>
<description><![CDATA[
<p>Pur has been implicated in mRNA transport and translation in neurons. We previously reported that Pur is a component of mRNA/protein complexes (Pur-mRNPs) with several other proteins. Among them, we found the C9orf10 (<I>Homo sapiens</I> chromosome 9 open reading frame 10) protein, which was recently characterized as a component of RNA-containing structures. However, C9orf10 itself remains poorly understood. To characterize C9orf10 expression at the protein level, we raised an antibody against C9orf10 and compared the spatial and developmental expressions of this protein and Pur in the mouse brain. C9orf10 was expressed as early as embryo stage 12, whereas Pur was expressed from 5 days after birth. In adults, C9orf10 expression was most prominent in the hippocampus, caudate putamen, cerebral cortex, and cerebellum, unlike the uniform distribution of Pur. C9orf10-positive cells also showed immunoreactivity to Pur. C9orf10 expression was restricted to neurons, judging by the immunoreactivity to neuron-specific nuclear protein or CaM kinase II. These observations suggest an accessory role of C9orf10 for Pur in a limited brain region in addition to other possible functions that have not yet been determined. <b>(J Histochem Cytochem 56:723&ndash;731, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Kobayashi, Y., Suzuki, K., Kobayashi, H., Ohashi, S., Koike, K., Macchi, P., Kiebler, M., Anzai, K.]]></dc:creator>
<dc:date>2008-07-07</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950733</dc:identifier>
<dc:title><![CDATA[C9orf10 Protein, a Novel Protein Component of Pur{alpha}-containing mRNA-protein Particles (Pur{alpha}-mRNPs): Characterization of Developmental and Regional Expressions in the Mouse Brain]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>731</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>723</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/8/733?rss=1">
<title><![CDATA[Expression of Somatostatin and Somatostatin Receptor Subtypes 1-5 in Human Normal and Diseased Kidney]]></title>
<link>http://www.jhc.org/cgi/content/short/56/8/733?rss=1</link>
<description><![CDATA[
<p>Somatostatin mediates inhibitory functions through five G protein&ndash;coupled somatostatin receptors (sst<SUB>1&ndash;5</SUB>). We used immunohistochemistry, immunofluorescence, and RT-PCR to determine the presence of somatostatin receptors sst<SUB>1</SUB>, sst<SUB>2A</SUB>, sst<SUB>2B</SUB>, sst<SUB>3</SUB>, sst<SUB>4</SUB>, and sst<SUB>5</SUB> in normal and IgA nephropathy human kidney. All somatostatin receptors were detected in the thin tubules (distal convoluted tubules and loops of Henle) and thick tubules (proximal convoluted tubules) in the tissue sections from nephrectomy and biopsy samples. Immunopositive sst<SUB>1</SUB> and sst<SUB>4</SUB> staining was more condensed in the cytoplasm of tubular epithelial cells. In normal kidney tissue sections, podocytes and mesangial cells in the glomeruli stained for sst<SUB>1</SUB>, sst<SUB>2B</SUB>, sst<SUB>4</SUB> and sst<SUB>5</SUB>, and stained weakly for sst<SUB>3</SUB>. In IgA kidney tissue, the expression of somatostatin receptors was significantly increased with particular immmunopositive staining for sst<SUB>1</SUB>, sst<SUB>2B</SUB>, sst<SUB>4</SUB>, and sst<SUB>5</SUB> within glomeruli. In the epithelial cells, the staining for sst<SUB>2B</SUB> and sst<SUB>4</SUB> in proximal tubules and sst<SUB>1</SUB>, sst<SUB>2B</SUB>, and sst<SUB>5</SUB> in distal tubules was increased. The mRNA expression of sst<SUB>1&ndash;5</SUB> was also detected by RT-PCR. Somatostatin and all five receptor subtypes were ubiquitously distributed in normal kidney and IgA nephropathy. The increased expression of somatostatin receptors in IgA nephropathy kidney might be the potential pathogenesis of inflammatory renal disease. <b>(J Histochem Cytochem 56:733&ndash;743, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Bhandari, S., Watson, N., Long, E., Sharpe, S., Zhong, W., Xu, S.-Z., Atkin, S. L.]]></dc:creator>
<dc:date>2008-07-07</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950998</dc:identifier>
<dc:title><![CDATA[Expression of Somatostatin and Somatostatin Receptor Subtypes 1-5 in Human Normal and Diseased Kidney]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>743</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>733</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/8/745?rss=1">
<title><![CDATA[Diabetes Reduces Aortic Endothelial Gap Junctions in ApoE-deficient Mice: Simvastatin Exacerbates the Reduction]]></title>
<link>http://www.jhc.org/cgi/content/short/56/8/745?rss=1</link>
<description><![CDATA[
<p>We examined the endothelial gap junctions in diabetic hyperlipidemic mice. Male apolipoprotein E (apoE)-deficient mice were made diabetic by streptozotocin. Three weeks later, the animals were treated with simvastatin for 2 weeks. The expression of aortic gap junctions in the non-diabetic (<I>n</I>=10), untreated diabetic (<I>n</I>=10), and simvastatin-treated diabetic animals (<I>n</I>=6) was analyzed. There was a &gt;4-fold increase in serum cholesterol level and &gt;50% increase in plaque areas in the diabetic mice, regardless of simvastatin treatment. Western blotting of aortae showed reduced expression of connexin37 (Cx37) and Cx40 in the diabetic mice, which were further decreased in the simvastatin-treated diabetic mice. Immunoconfocal microscopy showed that endothelial gap junctions made of Cx37 and Cx40 were both reduced in the untreated diabetic mice compared with the non-diabetic mice (decrease: Cx37, 41%; Cx40, 42%; both <I>p</I>&lt;0.01). The reduction was greater in the simvastatin-treated mice (decrease in treated diabetic vs non-diabetic: Cx37, 61%; Cx40, 79%; both <I>p</I>&lt;0.01; decrease in treated diabetic vs untreated diabetic: Cx37, 34%; Cx40, 63%; both <I>p</I>&lt;0.01). Cx37 and Cx40 were decreased in the endothelium of plaque surface. Cx43 appeared in the medial layer and inner layer of the intima. All three connexins were rarely expressed in monocytes/macrophages inside the plaques. In conclusion, in apoE-deficient mice, streptozotocin-induced diabetes is associated with downregulation of endothelial Cx37 and Cx40 gap junctions. Short-term treatment with simvastatin exacerbates the downregulation. <b>(J Histochem Cytochem 56:745&ndash;752, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Hou, C. J.-Y., Tsai, C.-H., Su, C.-H., Wu, Y.-J., Chen, S.-J., Chiu, J.-J., Shiao, M.-S., Yeh, H.-I]]></dc:creator>
<dc:date>2008-07-07</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950816</dc:identifier>
<dc:title><![CDATA[Diabetes Reduces Aortic Endothelial Gap Junctions in ApoE-deficient Mice: Simvastatin Exacerbates the Reduction]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>752</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>745</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/8/753?rss=1">
<title><![CDATA[Periostin Is Expressed in Pericryptal Fibroblasts and Cancer-associated Fibroblasts in the Colon]]></title>
<link>http://www.jhc.org/cgi/content/short/56/8/753?rss=1</link>
<description><![CDATA[
<p>Periostin is a unique extracellular matrix protein, deposition of which is enhanced by mechanical stress and the tissue repair process. Its significance in normal and neoplastic colon has not been fully clarified yet. Using immunohistochemistry and immunoelectron microscopy with a highly specific monoclonal antibody, periostin deposition was observed in close proximity to pericryptal fibroblasts of colonic crypts. The pericryptal pattern of periostin deposition was decreased in adenoma and adenocarcinoma, preceding the decrease of the number of pericryptal fibroblasts. Periostin immunoreactivity appeared again at the invasive front of the carcinoma and increased along the appearance of cancer-associated fibroblasts. ISH showed periostin signals in cancer-associated fibroblasts but not in cancer cells. Ki-67&ndash;positive epithelial cells were significantly decreased in the colonic crypts of periostin<sup>&ndash;/&ndash;</sup> mice (~0.6-fold) compared with periostin<sup>+/+</sup> mice. In three-dimensional co-culture within type I collagen gel, both colony size and number of human colon cancer cell line HCT116 cells were significantly larger (~1.5-fold) when cultured with fibroblasts derived from periostin<sup>+/+</sup> mice or periostin-transfected NIH3T3 cells than with those from periostin<sup>&ndash;/&ndash;</sup> mice or periostin&ndash;non-producing NIH3T3 cells, respectively. Periostin is secreted by pericryptal and cancer-associated fibroblasts in the colon, both of which support the growth of epithelial components. <b>(J Histochem Cytochem 56:753&ndash;764, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Kikuchi, Y., Kashima, T. G., Nishiyama, T., Shimazu, K., Morishita, Y., Shimazaki, M., Kii, I., Horie, H., Nagai, H., Kudo, A., Fukayama, M.]]></dc:creator>
<dc:date>2008-07-07</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.951061</dc:identifier>
<dc:title><![CDATA[Periostin Is Expressed in Pericryptal Fibroblasts and Cancer-associated Fibroblasts in the Colon]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>764</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>753</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/8/765?rss=1">
<title><![CDATA[Expression of Calcyclin-binding Protein/Siah-1 Interacting Protein in Normal and Malignant Human Tissues: An Immunohistochemical Survey]]></title>
<link>http://www.jhc.org/cgi/content/short/56/8/765?rss=1</link>
<description><![CDATA[
<p>Calcyclin-binding protein (CacyBP)/Siah-1 interacting protein (SIP), a component of ubiquitin-mediated proteolysis, could bind the Skp1-Cul1-F box protein complex. Although CacyBP/SIP was implicated in p53-induced &beta;-catenin degradation, its exact function was still unknown. Our previous studies showed that CacyBP/SIP could modulate the multidrug-resistant phenotype of gastric cancer cells and was highly expressed in gastric cancer tissues compared with that in non-cancerous tissues. In this study, CacyBP/SIP protein expression profile in a broad range of human normal tissues and carcinomas was analyzed by immunohistochemistry staining with anti-CacyBP/SIP monoclonal antibody first produced in our laboratory. CacyBP/SIP was generally localized in the cytoplasm/nucleus. Positive staining of CacyBP/SIP was found in brain, heart, lymph node, and esophagus. Weak staining was shown in the rectum and kidney. No CacyBP/SIP was detected in other normal tissues. However, CacyBP/SIP was ubiquitously detected in all kinds of tumor tissues and was highly expressed in nasopharyngeal carcinoma, osteogenic sarcoma, and pancreatic cancer. To our knowledge, this is the first study on the CacyBP/SIP expression pattern in a broad range of human normal and tumor tissues. The data presented should serve as a useful reference for other investigators in future studies of CacyBP/SIP functions. Hopefully, this knowledge will lead to discovery of more roles of CacyBP/SIP in tumorigenesis. <b>(J Histochem Cytochem 56:765&ndash;772, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Zhai, H., Shi, Y., Jin, H., Li, Y., Lu, Y., Chen, X., Wang, J., Ding, L., Wang, X., Fan, D.]]></dc:creator>
<dc:date>2008-07-07</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950519</dc:identifier>
<dc:title><![CDATA[Expression of Calcyclin-binding Protein/Siah-1 Interacting Protein in Normal and Malignant Human Tissues: An Immunohistochemical Survey]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>772</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>765</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/8/773?rss=1">
<title><![CDATA[Expression and Localization of Lectin-like Oxidized Low-density Lipoprotein Receptor-1 (LOX-1) in Murine and Human Placentas]]></title>
<link>http://www.jhc.org/cgi/content/short/56/8/773?rss=1</link>
<description><![CDATA[
<p>Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is one of the scavenger receptors that recognizes oxidized low-density lipoprotein as a major ligand. The placenta is a major source of prooxidant during pregnancy, and the level of placental oxidative stress increases rapidly at the end of the first trimester and tapers off later in gestation. In our study, we evaluated placental expression of LOX-1 during different gestational stages in mice and humans. We used immunohistochemistry and ISH to identify LOX-1&ndash;expressing cells in murine and human placentas. In both species, higher expression of LOX-1 mRNA during early to midgestational stages compared with late gestation&mdash;corresponding to the increased oxidative stress in early pregnancy&mdash;was shown by real-time RT-PCR. In murine placenta, we showed that LOX-1&ndash;expressing cells were fibroblast-like stromal cells in metrial glands and decidua basalis and that they were glycogen trophoblast cells in the junctional and labyrinth zones. In the human, LOX-1 expression was detected in villous cytotrophoblasts in both first trimester and term placentas. These localization patterns of LOX-1 in murine and human placentas suggest the possible involvement of LOX-1 in high oxidative stress conditions of pregnancy. <b>(J Histochem Cytochem 56:773&ndash;784, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Satoh, H., Kiyota, E., Terasaki, Y., Sawamura, T., Takagi, K., Mizuta, H., Takeya, M.]]></dc:creator>
<dc:date>2008-07-07</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950543</dc:identifier>
<dc:title><![CDATA[Expression and Localization of Lectin-like Oxidized Low-density Lipoprotein Receptor-1 (LOX-1) in Murine and Human Placentas]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>784</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>773</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/8/785?rss=1">
<title><![CDATA[Connective Tissue Growth Factor Is Necessary for Retinal Capillary Basal Lamina Thickening in Diabetic Mice]]></title>
<link>http://www.jhc.org/cgi/content/short/56/8/785?rss=1</link>
<description><![CDATA[
<p>Experimental prevention of basal lamina (BL) thickening of retinal capillaries ameliorates early vascular changes caused by diabetes. Connective tissue growth factor (CTGF) is upregulated early in diabetes in the human retina and is a potent inducer of expression of BL components. We hypothesize that CTGF is causally involved in diabetes-induced BL thickening of retinal capillaries. To test this hypothesis, we compared the effects of streptozotocin (STZ)-induced diabetes on retinal capillary BL thickness between wild-type mice (CTGF<sup>+/+</sup>) and mice lacking one functional CTGF allele (CTGF<sup>+/&ndash;</sup>). Differences in BL thickness were calculated by quantitative analysis of electron microscopic images of transversally sectioned capillaries in and around the inner nuclear layer of the retina. We show that BL thickening was significant in diabetic CTGF<sup>+/+</sup> mice compared with control CTGF<sup>+/+</sup> mice, whereas diabetes did not significantly induce BL thickening in CTGF<sup>+/&ndash;</sup> mice. We conclude that CTGF expression is necessary for diabetes-induced BL thickening and suggest that reduction of CTGF levels may be protective against the development of diabetic retinopathy. <b>(J Histochem Cytochem 56:785&ndash;792, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Kuiper, E. J., van Zijderveld, R., Roestenberg, P., Lyons, K. M., Goldschmeding, R., Klaassen, I., Van Noorden, C. J.F., Schlingemann, R. O.]]></dc:creator>
<dc:date>2008-07-07</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950980</dc:identifier>
<dc:title><![CDATA[Connective Tissue Growth Factor Is Necessary for Retinal Capillary Basal Lamina Thickening in Diabetic Mice]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>792</prism:endingPage>
<prism:publicationDate>2008-08-01</prism:publicationDate>
<prism:startingPage>785</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/7/629?rss=1">
<title><![CDATA[Effects of a Mixture of Growth Factors and Proteins on the Development of the Osteogenic Phenotype in Human Alveolar Bone Cell Cultures]]></title>
<link>http://www.jhc.org/cgi/content/short/56/7/629?rss=1</link>
<description><![CDATA[
<p>Strategies to promote bone repair have included exposure of cells to growth factor (GF) preparations from blood that generally include proteins as part of a complex mixture. This study aimed to evaluate the effects of such a mixture on different parameters of the development of the osteogenic phenotype in vitro. Osteoblastic cells were obtained by enzymatic digestion of human alveolar bone and cultured under standard osteogenic conditions until subconfluence. They were subcultured on Thermanox coverslips up to 14 days. Treated cultures were exposed during the first 7 days to osteogenic medium supplemented with a GFs + proteins mixture containing the major components found in platelet extracts [platelet-derived growth factor-BB, transforming growth factor (TGF)-&beta;1, TGF-&beta;2, albumin, fibronectin, and thrombospondin] and to osteogenic medium alone thereafter. Control cultures were exposed only to the osteogenic medium. Treated cultures exhibited a significantly higher number of adherent cells from day 4 onward and of cycling cells at days 1 and 4, weak alkaline phosphatase (ALP) labeling, and significantly decreased levels of ALP activity and mRNA expression. At day 14, no Alizarin red&ndash;stained nodular areas were detected in cultures treated with GFs + proteins. Results were confirmed in the rat calvaria&ndash;derived osteogenic cell culture model. The addition of bone morphogenetic protein 7 or growth and differentiation factor 5 to treated cultures upregulated Runx2 and ALP mRNA expression, but surprisingly, ALP activity was not restored. These results showed that a mixture of GFs + proteins affects the development of the osteogenic phenotype both in human and rat cultures, leading to an increase in the number of cells, but expressed a less differentiated state. <b>(J Histochem Cytochem 56:629&ndash;638, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[de Oliveira, P. T., de Oliva, M. A., Maximiano, W. M. A., Sebastiao, K. E. V., Crippa, G. E., Ciancaglini, P., Beloti, M. M., Nanci, A., Rosa, A. L.]]></dc:creator>
<dc:date>2008-06-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950758</dc:identifier>
<dc:title><![CDATA[Effects of a Mixture of Growth Factors and Proteins on the Development of the Osteogenic Phenotype in Human Alveolar Bone Cell Cultures]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>638</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>629</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/7/639?rss=1">
<title><![CDATA[Differential Expression of Decorin by Human Malignant and Benign Vascular Tumors]]></title>
<link>http://www.jhc.org/cgi/content/short/56/7/639?rss=1</link>
<description><![CDATA[
<p>An increasing amount of evidence indicates that a small extracellular chondroitin/dermatan sulfate proteoglycan, decorin, is indirectly involved in angiogenesis. Given that angiogenesis is a sine qua non for tumor growth and progression, we attempted to examine whether human malignant vascular tumors differ from human benign vascular tumors in terms of their decorin expression and synthesis. CD31 immunostaining demonstrated that the human malignant vascular tumors Kaposi's sarcoma and angiosarcoma were filled with capillary-like structures, whereas in benign cavernous and capillary hemangiomas, blood vessels were not as abundantly present. By utilizing in situ hybridization and immunocytochemical assays for decorin, we showed that there was no detectable decorin mRNA expression or immunoreactivity within the tumor mass in the Kaposi's sarcoma or angiosarcoma group. Instead, decorin was expressed in the connective tissue stroma lining the sarcoma tissue. In contrast to sarcomas, in hemangiomas, decorin mRNA expression and immunoreactivity were observed also within the tumor mass, particularly in the connective tissue stroma surrounding the clusters of intratumoral blood vessels. Finally, distribution of type I collagen was found to be similar to that of decorin in these tumor tissues. Our findings can be explained with different states of angiogenesis in dissimilar growths. In sarcomas, angiogenesis is extremely powerful, whereas in hemangiomas, angiogenesis has ceased. Thus, decorin is likely to possess a suppressive effect on human tumor angiogenesis in vivo, as previously described by studies using different experimental models. Decorin certainly provides a usable biomarker for distinguishing between benign and malignant vascular tumors in patients. <b>(J Histochem Cytochem 56:639&ndash;646, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Salomaki, H. H., Sainio, A. O., Soderstrom, M., Pakkanen, S., Laine, J., Jarvelainen, H. T.]]></dc:creator>
<dc:date>2008-06-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950287</dc:identifier>
<dc:title><![CDATA[Differential Expression of Decorin by Human Malignant and Benign Vascular Tumors]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>646</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>639</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/7/647?rss=1">
<title><![CDATA[Production and Histological Application of Affinity-purified Antibodies to Heat-denatured Green Fluorescent Protein]]></title>
<link>http://www.jhc.org/cgi/content/short/56/7/647?rss=1</link>
<description><![CDATA[
<p>Enhanced green fluorescent protein (GFP) irreversibly loses not only fluorescence but also antigenicity recognized with conventional anti-GFP antibodies by heat denaturation. This hinders combinatory applications of the GFP immunodetection technique with heat-requiring procedures, such as in situ hybridization histochemistry, antigen retrieval, and Western blot. Here we produced new rabbit and guinea pig antibodies against heat-denatured GFP. The polyclonal antibodies affinity-purified with the antigen column detected a single band corresponding to the molecular size of GFP in Western blot analysis, with mouse brain expressing GFP from the GAD67 locus. By immunofluorescence labeling, the new antibodies detected GFP molecules in heat (&ge;70C)-treated sections but not in untreated sections of the mouse brain. When the sections were incubated at &ge;37C with in situ hybridization buffer containing 50% formamide, a denaturing reagent, the sections lost immunoreactivity with the conventional anti-GFP antibodies but acquired immunoreactivity with the new antibodies to heat-denatured GFP. Finally, GFP immunofluorescence was successfully visualized with the new antibodies in sections of the GFP-expressing mice labeled by fluorescence in situ hybridization histochemistry against GAD67 mRNA. Thus, the antibodies produced in this study may provide an opportunity to combine GFP immunodetection with procedures requiring heat treatment. This manuscript contains online supplemental material at <inter-ref locator="http://www.jhc.org" locator-type="URL">http://www.jhc.org</inter-ref>. Please visit this article online to view these materials. <b>(J Histochem Cytochem 56:647&ndash;657, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Nakamura, K. C., Kameda, H., Koshimizu, Y., Yanagawa, Y., Kaneko, T.]]></dc:creator>
<dc:date>2008-06-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950915</dc:identifier>
<dc:title><![CDATA[Production and Histological Application of Affinity-purified Antibodies to Heat-denatured Green Fluorescent Protein]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>657</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>647</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/7/659?rss=1">
<title><![CDATA[Site-specific Expression of IQGAP1, a Key Mediator of Cytoskeleton, in Mouse Renal Tubules]]></title>
<link>http://www.jhc.org/cgi/content/short/56/7/659?rss=1</link>
<description><![CDATA[
<p>IQGAP1 is a multifunctional junction molecule that is involved in cell migration, proliferation, differentiation, cell polarity, and cell&ndash;cell adhesion. It is highly expressed in the kidney and has recently been identified in the glomerular basement membrane as a nephrin-associated protein. However, the distribution of IQGAP1 in renal tubular epithelial cells is unknown. We performed confocal microscopic studies to localize IQGAP1 in each nephron segment using dual immunofluorescence staining with various antibodies against segment-specific markers. We found that IQGAP1 was strongly expressed in the distal convoluted tubule (DCT), collecting duct, and macula densa and moderately in the thick ascending limb and proximal tubule. In the DCT, the IQGAP1&ndash;F-actin complex forms a comb-like structure with multiple parallel spikes sitting on the basal membrane. In the macula densa cells, IQGAP1 is strongly expressed in the apical membrane, whereas in type A intercalated cells, IQGAP1 is expressed in the basolateral membrane, where it colocalizes with anion exchanger 1, and in principal cells, it is diffusely expressed. In conclusion, we showed the expression and subcellular localization of IQGAP1 in various nephron segments. The site-specific expression pattern of this potent modulator of multiple biological pathways in the renal tubules suggests that IQGAP1 may have multiple important roles in various renal functions. <b>(J Histochem Cytochem 56:659&ndash;666, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Lai, L.-W., Yong, K.-C., Lien, Y.-H. H.]]></dc:creator>
<dc:date>2008-06-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950113</dc:identifier>
<dc:title><![CDATA[Site-specific Expression of IQGAP1, a Key Mediator of Cytoskeleton, in Mouse Renal Tubules]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>666</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>659</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/7/667?rss=1">
<title><![CDATA[Phenotypic and Genetic Characterization of Circulating Tumor Cells by Combining Immunomagnetic Selection and FICTION Techniques]]></title>
<link>http://www.jhc.org/cgi/content/short/56/7/667?rss=1</link>
<description><![CDATA[
<p>The presence of circulating tumor cells (CTCs) in breast cancer patients has been proven to have clinical relevance. Cytogenetic characterization of these cells could have crucial relevance for targeted cancer therapies. We developed a method that combines an immunomagnetic selection of CTCs from peripheral blood with the fluorescence immunophenotyping and interphase cytogenetics as a tool for investigation of neoplasm (FICTION) technique. Briefly, peripheral blood (10 ml) from healthy donors was spiked with a predetermined number of human breast cancer cells. Nucleated cells were separated by double density gradient centrifugation of blood samples. Tumor cells (TCs) were immunomagnetically isolated with an anti-cytokeratin antibody and placed onto slides for FICTION analysis. For immunophenotyping and genetic characterization of TCs, a mixture of primary monoclonal anti-pancytokeratin antibodies was used, followed by fluorescent secondary antibodies, and finally hybridized with a TOP2A/HER-2/CEP17 multicolor probe. Our results show that TCs can be efficiently isolated from peripheral blood and characterized by FICTION. Because genetic amplification of <I>TOP2A</I> and <I>ErbB2</I> (<I>HER-2</I>) in breast cancer correlates with response to anthracyclines and herceptin therapies, respectively, this novel methodology could be useful for a better classification of patients according to the genetic alterations of CTCs and for the application of targeted therapies. <b>(J Histochem Cytochem 56:667&ndash;675, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Campos, M., Prior, C., Warleta, F., Zudaire, I., Ruiz-Mora, J., Catena, R., Calvo, A., Gaforio, J. J.]]></dc:creator>
<dc:date>2008-06-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.951111</dc:identifier>
<dc:title><![CDATA[Phenotypic and Genetic Characterization of Circulating Tumor Cells by Combining Immunomagnetic Selection and FICTION Techniques]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>675</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>667</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/7/677?rss=1">
<title><![CDATA[Leptin and the Obesity Receptor (OB-R) in the Small Intestine and Colon: A Colocalization Study]]></title>
<link>http://www.jhc.org/cgi/content/short/56/7/677?rss=1</link>
<description><![CDATA[
<p>Leptin is a hormone that plays an important role in overall body energy homeostasis, and the obesity receptor, OB-R, is widely distributed in the organism. In the intestine, a multitude of leptin actions have been reported, but it is currently unclear to what extent the hormone affects the intestinal epithelial cells by an endocrine or exocrine signaling pathway. To elucidate this, the localization of endogenous porcine leptin and OB-R in enterocytes and colonocytes was studied. By immunofluorescence microscopy, both leptin and OB-R were mainly observed in the basolateral membrane of enterocytes and colonocytes but also in the apical microvillar membrane of the cells. By electron microscopy, coclustering of hormone and receptor in the plasma membrane and localization in endosomes was frequently detected at the basolateral surface of the epithelial cells, indicative of leptin signaling activity. In contrast, coclustering occurred less frequently at the apical cell surface, and subapical endosomal localization was hardly detectable. We conclude that leptin action in intestinal epithelial cells takes place at the basolateral plasma membrane, indicating that the hormone uses an endocrine pathway both in the jejunum and colon. In contrast, the data obtained did not provide evidence for an exocrine, lumenal action of the hormone in the intestine. <b>(J Histochem Cytochem 56:677&ndash;685, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Hansen, G. H., Niels-Christiansen, L.-L., Danielsen, E. M.]]></dc:creator>
<dc:date>2008-06-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950782</dc:identifier>
<dc:title><![CDATA[Leptin and the Obesity Receptor (OB-R) in the Small Intestine and Colon: A Colocalization Study]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>685</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>677</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/7/687?rss=1">
<title><![CDATA[Keratinocyte Migration, Proliferation, and Differentiation in Chronic Ulcers From Patients With Diabetes and Normal Wounds]]></title>
<link>http://www.jhc.org/cgi/content/short/56/7/687?rss=1</link>
<description><![CDATA[
<p>Epithelialization of normal acute wounds occurs by an orderly series of events whereby keratinocytes migrate, proliferate, and differentiate to restore barrier function. The keratinocytes in the epidermis of chronic ulcers fail to execute this series of events. To better understand the epithelial dynamics of chronic ulcers, we used immunohistochemistry to evaluate proliferation, differentiation, adhesion, and migration in keratinocytes along the margin of chronic ulcers from patients with diabetes mellitus. We compared these features with keratinocytes from the migrating epithelial tongues of acute incisional and excisional wounds from normal volunteers. Keratinocytes at the chronic ulcer edge are highly proliferative (Ki67 proliferation marker), have an activated phenotype (K16), do not stain for keratins involved in epidermal differentiation (K10 and K2), and show a reduced expression of LM-3A32 (uncleaved, precursor of the 3 chain of laminin 5), a key molecule present on migrating epithelium. In contrast, keratinocytes in normal acute wound migrating epithelium do not express the proliferation marker Ki67 but do express K10, K2, and LM-3A32. A better understanding of molecular mechanisms involved in keratinocyte migration may lead to molecular targets for therapies for impaired wound healing. <b>(J Histochem Cytochem 56:687&ndash;696, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Usui, M. L., Mansbridge, J. N., Carter, W. G., Fujita, M., Olerud, J. E.]]></dc:creator>
<dc:date>2008-06-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.951194</dc:identifier>
<dc:title><![CDATA[Keratinocyte Migration, Proliferation, and Differentiation in Chronic Ulcers From Patients With Diabetes and Normal Wounds]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>696</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>687</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/7/697?rss=1">
<title><![CDATA[Rapid Microwave Fixation of Cell Monolayers Preserves Microtubule-associated Cell Structures]]></title>
<link>http://www.jhc.org/cgi/content/short/56/7/697?rss=1</link>
<description><![CDATA[
<p>Microwave (MW) fixation has been suggested as a method to rapidly immobilize cellular dynamics for fine structural studies in the electron microscope. To show its suitability for studies on cell monolayers, one has to apply MW fixation systematically in correlation with samples on the light microscopy level. Examples for MW fixation of cell monolayers, however, are still rare. MW-accelerated fixation for relatively long periods of time (1&ndash;2 min) has been reported without showing its suitability at the fine structural level. Here, we provide a rapid MW fixation protocol for cell monolayers on a subminute time scale. The impact of the MW-accelerated glutaraldehyde fixation on temperature-sensitive cytoskeletal components such as microtubules was evaluated. For testing the effectiveness of MW-assisted primary fixation, saponin treatment of the monolayers was included. Simultaneous MW-accelerated fixation and extraction by saponin was necessary to achieve a gradual improvement in visualization of cytoskeletal aspects in association with cell junctions, mitochondria, and centrioles. To establish a valuable routine program for fine structural studies of resin-embedded cell models on substrata, a protocol combining MW fixation with automatic processing in a tissue processor is provided. <b>(J Histochem Cytochem 56:697&ndash;709, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Reipert, S., Kotisch, H., Wysoudil, B., Wiche, G.]]></dc:creator>
<dc:date>2008-06-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.7A7370.2008</dc:identifier>
<dc:title><![CDATA[Rapid Microwave Fixation of Cell Monolayers Preserves Microtubule-associated Cell Structures]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>709</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>697</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/531?rss=1">
<title><![CDATA[Preparation of Polyclonal Antibody Specific for BRD7 and Detection of Its Expression Pattern in the Human Fetus]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/531?rss=1</link>
<description><![CDATA[
<p><I>BRD7</I> is a novel bromodomain gene. It plays critical role in cell growth, cell cycle progression, and signal-dependent gene expression. Overexpression of the <I>BRD7</I> gene in nasopharyngeal carcinoma cells is effective to inhibit cell growth and cell cycle progression from G1 to S phase. However, little is known about its bio-functions because of the unavailability of a specific BRD7 antibody. In this study, for the first time, we generated a highly specific BRD7 antibody. It is able to specifically recognize recombinant GST-BRD7N protein with a molecular mass of 65 kDa and recognize BRD7-Myc and endogenously expressed BRD7 protein with an approximate molecular mass of 75 kDa, which corresponds well with the calculated molecular mass of the BRD7 protein. More importantly, with these antisera, we analyzed BRD7 distribution in the human fetus by Western blot and immunohistochemistry assays. Obvious nuclear expression of BRD7 protein presents in human cerebellum, pancreas, intestines, liver, and kidney. Cardiomyocyte shows high cytoplasm expression of the BRD7 protein. Weak nuclear expression of the BRD7 protein is found in human cerebrum, lung, and stomach. These data may help to further study the cellular role of the <I>BRD7</I> gene. In particular, the prepared BRD7 antibody will be helpful for studying the bio-functions of endogenously expressed BRD7 protein. <b>(J Histochem Cytochem 56:531&ndash;538, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Liu, H., Li, X., Niu, Z., Zhang, L., Zhou, M., Huang, H., He, J., Zhang, W., Xiao, L., Tang, Y., Wang, L., Li, G.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.7A7340.2007</dc:identifier>
<dc:title><![CDATA[Preparation of Polyclonal Antibody Specific for BRD7 and Detection of Its Expression Pattern in the Human Fetus]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>538</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>531</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/539?rss=1">
<title><![CDATA[A Rapid Method Combining Golgi and Nissl Staining to Study Neuronal Morphology and Cytoarchitecture]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/539?rss=1</link>
<description><![CDATA[
<p>The Golgi silver impregnation technique gives detailed information on neuronal morphology of the few neurons it labels, whereas the majority remain unstained. In contrast, the Nissl staining technique allows for consistent labeling of the whole neuronal population but gives very limited information on neuronal morphology. Most studies characterizing neuronal cell types in the context of their distribution within the tissue slice tend to use the Golgi silver impregnation technique for neuronal morphology followed by deimpregnation as a prerequisite for showing that neuron's histological location by subsequent Nissl staining. Here, we describe a rapid method combining Golgi silver impregnation with cresyl violet staining that provides a useful and simple approach to combining cellular morphology with cytoarchitecture without the need for deimpregnating the tissue. Our method allowed us to identify neurons of the facial nucleus and the supratrigeminal nucleus, as well as assessing cellular distribution within layers of the dorsal cochlear nucleus. With this method, we also have been able to directly compare morphological characteristics of neuronal somata at the dorsal cochlear nucleus when labeled with cresyl violet with those obtained with the Golgi method, and we found that cresyl violet&ndash;labeled cell bodies appear smaller at high cellular densities. Our observation suggests that cresyl violet staining is inadequate to quantify differences in soma sizes. <b>(J Histochem Cytochem 56:539&ndash;550, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Pilati, N., Barker, M., Panteleimonitis, S., Donga, R., Hamann, M.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950246</dc:identifier>
<dc:title><![CDATA[A Rapid Method Combining Golgi and Nissl Staining to Study Neuronal Morphology and Cytoarchitecture]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>550</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>539</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/551?rss=1">
<title><![CDATA[Distribution and Expression of Soluble Epoxide Hydrolase in Human Brain]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/551?rss=1</link>
<description><![CDATA[
<p>Epoxyeicosatrienoic acids (EETs) are cytochrome P450 metabolites of arachidonic acid, which function in the brain to regulate cerebral blood flow and protect against ischemic brain injury. EETs are converted by soluble epoxide hydrolase (sEH) to the corresponding inactive diol metabolites. Previous animal studies have indicated that sEH gene deletion or treatment with sEH inhibitors results in increased levels of EETs and protection against stroke-induced brain damage. To begin elucidating the underlying mechanism for these effects, we sought to determine the distribution, expression, and activity of sEH in human brain samples obtained from patients with no neurological changes/pathologies. Immunohistochemical analyses showed the distribution of sEH mainly in the neuronal cell bodies, oligodendrocytes, and scattered astrocytes. Surprisingly, in the choroid plexus, sEH was found to be highly expressed in ependymal cells. Vascular localization of sEH was evident in several regions, where it was highly expressed in the smooth muscles of the arterioles. Western blot analysis and enzyme assays confirmed the presence of sEH in the normal brain. Our results indicate differential localization of sEH in the human brain, thus suggestive of an essential role for this enzyme in the central nervous system. This manuscript contains online supplemental material at <inter-ref locator="http://www.jhc.org" locator-type="URL">http://www.jhc.org</inter-ref>. Please visit this article online to view these materials. <b>(J Histochem Cytochem 56:551&ndash;559, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Sura, P., Sura, R., EnayetAllah, A. E., Grant, D. F.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950659</dc:identifier>
<dc:title><![CDATA[Distribution and Expression of Soluble Epoxide Hydrolase in Human Brain]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>559</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>551</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/561?rss=1">
<title><![CDATA[Matrix Mineralization as a Trigger for Osteocyte Maturation]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/561?rss=1</link>
<description><![CDATA[
<p>The morphology of the osteocyte changes during the cell's lifetime. Shortly after becoming buried in the matrix, an osteocyte is plump with a rich rough endoplasmic reticulum and a well-developed Golgi complex. This "immature" osteocyte reduces its number of organelles to become a "mature" osteocyte when it comes to reside deeper in the bone matrix. We hypothesized that mineralization of the surrounding matrix is the trigger for osteocyte maturation. To verify this, we prevented mineralization of newly formed matrix by administration of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) and then examined the morphological changes in the osteocytes in rats. In the HEBP group, matrix mineralization was disturbed, but matrix formation was not affected. The osteocytes found in the unmineralized matrix were immature. Mature osteocytes were seen in the corresponding mineralized matrix in the control group. The immature osteocytes in the unmineralized matrix failed to show immunoreactivity with anti-sclerostin antibody, whereas mature osteocytes in the mineralized matrix showed immunoreactivity in both control and HEBP groups. These findings suggest that mineralization of the matrix surrounding the osteocyte is the trigger for cytodifferentiation from a plump immature form to a mature osteocyte. The osteocyte appears to start secreting sclerostin only after it matures in the mineralized bone matrix. <b>(J Histochem Cytochem 56:561&ndash;567, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Irie, K., Ejiri, S., Sakakura, Y., Shibui, T., Yajima, T.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950527</dc:identifier>
<dc:title><![CDATA[Matrix Mineralization as a Trigger for Osteocyte Maturation]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>567</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>561</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/569?rss=1">
<title><![CDATA[Expression and Synthesis of Bone Morphogenetic Proteins by Osteoclasts: A Possible Path to Anabolic Bone Remodeling]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/569?rss=1</link>
<description><![CDATA[
<p>Skeletal remodeling is a finely orchestrated process coupling bone formation to bone resorption. The dynamics of coupling is regulated by the microenvironment at the bone remodeling site, which in turn is influenced by the intercellular communication between cells like osteoclasts and osteoblasts. Understanding the dynamics of coupling is important in devising new therapeutic approaches to the treatment of skeletal diseases characterized by disturbances in the bone remodeling process. In this study, we report the localization of bone morphogenetic proteins (BMPs) in osteoclasts generated from primary cocultures of bone marrow cells from mouse femur and tibia with mouse calvarial osteoblasts, using immunocytochemistry and in situ hybridization. Positive staining was seen in osteoclasts for BMP-2, -4, -6, and -7. Real-time PCR was used to quantitatively confirm the expression of transcripts for BMP-2, BMP-4, and BMP-6 mRNA in murine osteoclasts. Finally, the presence of BMP-2, -4, -6, and-7 proteins was confirmed in osteoclast lysates by Western blotting. Overall, our data suggest a possible direct role for osteoclasts in promoting bone formation via expression and synthesis of BMPs, which then would play an important role in promoting the recruitment, proliferation, and differentiation of osteoblasts at bone resorption sites. <b>(J Histochem Cytochem 56:569&ndash;577, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Garimella, R., Tague, S. E., Zhang, J., Belibi, F., Nahar, N., Sun, B. H., Insogna, K., Wang, J., Anderson, H. C.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950394</dc:identifier>
<dc:title><![CDATA[Expression and Synthesis of Bone Morphogenetic Proteins by Osteoclasts: A Possible Path to Anabolic Bone Remodeling]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>577</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>569</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/579?rss=1">
<title><![CDATA[Mesothelin Expression in the Leptomeninges and Meningiomas]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/579?rss=1</link>
<description><![CDATA[
<p>The identity and functions of surface proteins on human leptomeningeal and meningioma cells are incompletely characterized. Some structural and functional similarities between the leptomeninges and pleura suggest that proteins important to pleural function and tumorigenesis might also be relevant to leptomeningeal disease. Mesothelin is a recently described, 40-kDa membrane protein expressed in pleura. Its functions in this tissue are under investigation. Sections of 20 normal adult brains with leptomeninges and 49 World Health Organization (WHO) grade I, 21 grade II, and 2 grade III meningiomas were analyzed using an extensively characterized monoclonal antibody to mesothelin and streptavidin-biotin complex immunohistochemistry. Five meningiomas were also evaluated by Western blot. Mesothelin immunoreactivity was detected in the arachnoid in 6 of 20 cases and in 23 of 49 WHO grade I meningiomas. It was also detected in 7 of 21 WHO II tumors and 1 of the 2 anaplastic meningiomas. By Western blot, all five meningiomas exhibited mesothelin precursor protein, including one where notable immunoreactivity was not identified in a formalin-fixed tissue section. These findings suggest that mesothelin is expressed in at least some arachnoid and meningioma cells. Future studies may clarify its role in the development of meningiomas, meningeal seeding of gliomas, and metastases to the leptomeninges. <b>(J Histochem Cytochem 56:579&ndash;585, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Johnson, M. D., Vito, F., O'Connell, M. J.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950477</dc:identifier>
<dc:title><![CDATA[Mesothelin Expression in the Leptomeninges and Meningiomas]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>585</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>579</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/587?rss=1">
<title><![CDATA[Generation and Characterization of Ptf1a Antiserum and Localization of Ptf1a in Relation to Nkx6.1 and Pdx1 During the Earliest Stages of Mouse Pancreas Development]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/587?rss=1</link>
<description><![CDATA[
<p>Ptf1a and Pdx1 are critical transcription factors of early pancreatic development, as shown by loss of function studies where lack of each gene alone causes almost complete pancreas agenesis. Ptf1a is particularly interesting because it is linked to a recently reported signature gene expression profile associated with the multipotent condition. Few useful antibody reagents have been available for consistent and reliable immunohistochemical visualization of Ptf1a protein expression in the early developing pancreas in which the level of production of this critical regulator seems to be very low. We describe a novel rabbit antibody raised against the c-terminal portion of the mouse Ptf1a protein and report immunodetection, for the first time, as early as embryonic day (e) 8.5&ndash;e8.75 in the dorsal and ventral buds of the mouse pancreas as well as in the neural tube at e10.0. Detailed confocal analysis identifies an abundant triple-positive (Ptf1a<sup>+</sup>/Nkx6.1<sup>+</sup>/Pdx1<sup>+</sup>) putative early multipotent pancreatic progenitor cell that marks the e9.5 dorsal pancreas and e10.5 ventral pancreas. Furthermore, expression patterns of Nkx6.1 vs Ptf1a subsequently segregate during branching morphogenesis (trunk vs tip), ending up marking two distinct cell populations of progenitors at e12.5. From e15.5 (mouse) and in adult pancreas (mouse, rat, and human), the Ptf1a antibody marks only acinar cell nuclei, as expected for its subsequent role in committing/maintaining cells in this differentiated state. In summary, this antibody is a novel tool to further characterize important early steps of pancreas differentiation. This manuscript contains online supplemental material at <inter-ref locator="http://www.jhc.org" locator-type="URL">http://www.jhc.org</inter-ref>. Please visit this article online to view these materials. <b>(J Histochem Cytochem 56:587&ndash;595, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Hald, J., Sprinkel, A. E., Ray, M., Serup, P., Wright, C., Madsen, O. D.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950675</dc:identifier>
<dc:title><![CDATA[Generation and Characterization of Ptf1a Antiserum and Localization of Ptf1a in Relation to Nkx6.1 and Pdx1 During the Earliest Stages of Mouse Pancreas Development]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>595</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>587</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/597?rss=1">
<title><![CDATA[Characteristics of the Phagocytic Cup Induced by Uropathogenic Escherichia coli]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/597?rss=1</link>
<description><![CDATA[
<p>Uropathogenic <I>Escherichia coli</I> invade the urothelial umbrella cells by using the zipper mechanism. However, the details of the early events of this invasion, such as the formation of the phagocytic cup, are not yet well understood. We show here, using thin section electron microscopy and immunogold labeling, that the plasma membrane curves around the bacterial surface in the phagocytic cup. There exists a uniform gap between the bacterium and the urothelial membrane, and actin filaments are present in the phagocytic cup. We suggest that the action&ndash;reaction between the mechanical forces generated by pilus retraction of the bacterium and the actin polymerization in the urothelial cell plays a role in maintaining the phagocytic cup. This manuscript contains online supplemental material at <inter-ref locator="http://www.jhc.org" locator-type="URL">http://www.jhc.org</inter-ref>. Please visit this article online to view these materials. <b>(J Histochem Cytochem 56:597&ndash;604, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Wang, H., Liang, F.-X., Kong, X.-P.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950923</dc:identifier>
<dc:title><![CDATA[Characteristics of the Phagocytic Cup Induced by Uropathogenic Escherichia coli]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>604</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>597</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/605?rss=1">
<title><![CDATA[Glomerular CD34 Expression in Short- and Long-term Diabetes]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/605?rss=1</link>
<description><![CDATA[
<p>Aging and diabetes are associated with exacerbated expression of adhesion molecules. Given their importance in endothelial dysfunction and their possible involvement in the alteration of glomerular permeability occurring in diabetes, we have evaluated expression of the sialomucin-type adhesion molecule CD34 in renal glomerular cells of normal and diabetic animals at two different ages by colloidal gold immunocytochemistry and immunoblotting. CD34 labeling was mostly assigned to the plasma membranes of glomerular endothelium and mesangial processes. Podocyte membranes were also labeled, but to a lesser degree. Short- and long-term diabetes triggers a substantial increase in immunogold labeling for CD34 in renal tissues compared with young normoglycemic animals. However, the level of labeling in old diabetic and healthy control rats is similar, suggesting that the effect of diabetes and aging on CD34 expression is similar but not synergistic. Western blotting of isolated glomerular fractions corroborated immunocytochemical results. Increased expression of CD34 may reflect its involvement in the pathogenesis of glomerular alterations related to age and diabetes. Alterations present in early diabetes, resembling those occurring with age, strengthen the concept that diabetes is an accelerated form of aging.<b>(J Histochem Cytochem 56:605&ndash;614, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Acevedo, L. M., Londono, I., Oubaha, M., Ghitescu, L., Bendayan, M.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.7A7354.2008</dc:identifier>
<dc:title><![CDATA[Glomerular CD34 Expression in Short- and Long-term Diabetes]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>614</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>605</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/6/615?rss=1">
<title><![CDATA[Aging Results in Increased Autophagy of Mitochondria and Protein Nitration in Rat Hepatocytes Following Heat Stress]]></title>
<link>http://www.jhc.org/cgi/content/short/56/6/615?rss=1</link>
<description><![CDATA[
<p>The natural breakdown of cells, tissues, and organ systems is a significant consequence of aging and is at least partially caused by a decreased ability to tolerate environmental stressors. Based on quantitative ultrastructural analysis using transmission electron microscopy and computer imaging, we show significant differences in hepatocyte morphology between young and old rats during a 48-hr recovery period following a 2-day heat stress protocol. Mitochondrial injury was greater overall in old compared with young rats. Autophagy was observed in both young and old rats, with autophagy greater overall in old compared with young hepatocytes. Lipid peroxidation and protein nitration were evaluated by localization and quantification of 4-hydroxy-2-nonenal (4-HNE)&ndash;modified protein adducts and 3-nitrotyrosine (3-NT) levels, respectively. Levels of 3-NT but not 4-HNE-protein adducts were significantly elevated in hepatocytes of old rats in comparison with young at 90 min after heat stress, suggesting a major role for reactive nitrogen species in the pathology observed at this time point. These results show a differential response of hepatocyte mitochondria to heat stress with aging, as well as greater levels of both autophagic and nitrative damage in old vs young hepatocytes. This manuscript contains online supplemental material at <inter-ref locator="http://www.jhc.org" locator-type="URL">http://www.jhc.org</inter-ref>. Please visit this article online to view these materials. <b>(J Histochem Cytochem 56:615&ndash;627, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Oberley, T. D., Swanlund, J. M., Zhang, H. J., Kregel, K. C.]]></dc:creator>
<dc:date>2008-05-16</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950873</dc:identifier>
<dc:title><![CDATA[Aging Results in Increased Autophagy of Mitochondria and Protein Nitration in Rat Hepatocytes Following Heat Stress]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>627</prism:endingPage>
<prism:publicationDate>2008-06-01</prism:publicationDate>
<prism:startingPage>615</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/5/425?rss=1">
<title><![CDATA[Expression of Aquaporin 9 in Rat Liver and Efferent Ducts of the Male Reproductive System After Neonatal Diethylstilbestrol Exposure]]></title>
<link>http://www.jhc.org/cgi/content/short/56/5/425?rss=1</link>
<description><![CDATA[
<p>Aquaporins (AQP) have important solute transport functions in many tissues including the epididymal efferent ducts (ED) and in the liver. We investigated the effect of neonatal exposure to diethylstilbestrol (DES) on AQP9 expressions in the ED and in the liver of rats. DES was administered from day 2 to day 20 postnatally at a dose of 4,8 &micro;g/day, and AQP9 protein and mRNA were measured by immunoblotting and real-time PCR, respectively, along with immunohistochemistry. DES caused hepatic downregulation of AQP9 at both the protein and mRNA level; however, decreased AQP9 labeling was only observed in the periportal zone. In the ED, AQP9 protein expression was increased in the DES-treated animals by 300% that could be ascribed to a widening of the ED lumen, whereas no difference was observed in AQP9 mRNA expression. Immunohistochemical findings revealed that AQP9 expression was confined to the epithelial cells of the ED. In conclusion, neonatal DES exposure appears to upregulate AQP9 channels in the ED in male rats, whereas a downregulation in the hepatic expression was observed, particularly in the periacinous area.<b>(J Histochem Cytochem 56:425&ndash;432, 2008)</b> </p>
]]></description>
<dc:creator><![CDATA[Wellejus, A., Jensen, H. E., Loft, S., Jonassen, T. E.]]></dc:creator>
<dc:date>2008-04-18</dc:date>
<dc:identifier>info:doi/10.1369/jhc.7A7366.2007</dc:identifier>
<dc:title><![CDATA[Expression of Aquaporin 9 in Rat Liver and Efferent Ducts of the Male Reproductive System After Neonatal Diethylstilbestrol Exposure]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>432</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>425</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/5/433?rss=1">
<title><![CDATA[Cellular Expression Patterns of Genes Upregulated in Murine and Human Colonic Neoplasms]]></title>
<link>http://www.jhc.org/cgi/content/short/56/5/433?rss=1</link>
<description><![CDATA[
<p>Markers overexpressed in colonic tumors of the multiple intestinal neoplasia (Min) mouse have been recently identified by cDNA subtractive hybridization and by microarray analysis. The significance of such a marker depends on its expression in tumor vs stromal lineages and on its expression pattern in normal tissue. From 34 differentially expressed markers, 14 were found to be expressed from supporting lineages. The markers expressed in the tumor lineage were grouped into three classes on the basis of ISH in mouse models and IHC in human adenomas. The first class includes markers expressed both in neoplastic cells and in the proliferating cells residing at the bottom of normal colonic crypts. The second class of markers shows elevated expression in neoplastic cells and also in the postmitotic Paneth cells of the small intestine. Finally, the third class of marker shows detectable intestinal expression only within tumors but not in the normal intestinal epithelium. Is such a tumor-associated marker uniquely essential for tumor growth? Deficiency for the tumor-associated glycoprotein clusterin does not affect the multiplicity or growth rate of intestinal tumors in Min mice. Thus, clusterin is a candidate secreted colon cancer marker but not a single target for chemoprevention or therapy. <b>(J Histochem Cytochem 56:433&ndash;441, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Chen, X., Ehrhardt, W. M., Halberg, R. B., Aronow, B. J., Dove, W. F.]]></dc:creator>
<dc:date>2008-04-18</dc:date>
<dc:identifier>info:doi/10.1369/jhc.7A7359.2008</dc:identifier>
<dc:title><![CDATA[Cellular Expression Patterns of Genes Upregulated in Murine and Human Colonic Neoplasms]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>441</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>433</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/5/443?rss=1">
<title><![CDATA[Voltage-gated Potassium Channel (Kv) Subunits Expressed in the Rat Cochlear Nucleus]]></title>
<link>http://www.jhc.org/cgi/content/short/56/5/443?rss=1</link>
<description><![CDATA[
<p>Because the neuronal membrane properties and firing characteristics are crucially affected by the depolarization-activated K<sup>+</sup> channel (Kv) subunits, data about the Kv distribution may provide useful information regarding the functionality of the neurons situated in the cochlear nucleus (CN). Using immunohistochemistry in free-floating slices, the distribution of seven Kv subunits was described in the rat CN. Positive labeling was observed for Kv1.1, 1.2, 1.6, 3.1, 3.4, 4.2, and 4.3 subunits. Giant and octopus neurons showed particularly strong immunopositivity for Kv3.1; octopus neurons showed intense Kv1.1- and 1.2-specific reactions also. In the latter case, an age-dependent change of the expression pattern was also documented; although both young and older animals produced definite labeling for Kv1.2, the intensity of the reaction increased in older animals and was accompanied with the translocation of the Kv1.2 subunits to the cell surface membrane. The granule cell layer exhibited strong Kv4.2-specific immunopositivity, and markedly Kv4.2-positive glomerular synapses were also seen. It was found that neither giant nor pyramidal cells were uniform in terms of their Kv expression patterns. Our data provide new information about the Kv expression of the CN and also suggest potential functional heterogeneity of the giant and pyramidal cells. <b>(J Histochem Cytochem 56:443&ndash;465, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Rusznak, Z., Bakondi, G., Pocsai, K., Por, A., Kosztka, L., Pal, B., Nagy, D., Szucs, G.]]></dc:creator>
<dc:date>2008-04-18</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950303</dc:identifier>
<dc:title><![CDATA[Voltage-gated Potassium Channel (Kv) Subunits Expressed in the Rat Cochlear Nucleus]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>465</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>443</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/5/467?rss=1">
<title><![CDATA[Colloidal-gold Immunocytochemical Localization of Osteopontin in Avian Eggshell Gland and Eggshell]]></title>
<link>http://www.jhc.org/cgi/content/short/56/5/467?rss=1</link>
<description><![CDATA[
<p>During mineralization of the avian eggshell, there is a sequential and orderly deposition of both matrix and mineral phases. Therefore, the eggshell is an excellent model for studying matrix&ndash;mineral relationships and the regulation of mineralization. Osteopontin, as an inhibitor of crystal growth, potently influences the formation of calcium phosphate and calcium carbonate biominerals. The purpose of this study was to characterize matrix&ndash;mineral relationships, specifically for osteopontin, in the avian eggshell using high-resolution transmission (TEM) and scanning (SEM) electron microscopy to gain insight into how calcite crystal growth is structured and compartmentalized during eggshell mineralization. Osteopontin was localized at the ultrastructural level by colloidal-gold immunocytochemistry. In EDTA-decalcified eggshell, an extensive matrix network was observed by TEM and SEM throughout all regions and included interconnected fibrous sheets, irregularly shaped aggregates, vesicular structures, protein films, and isolated protein fibers. Osteopontin was associated with protein sheets in the highly mineralized palisades region; some of these features defined boundaries that compartmentalized different eggshell structural units. In fractured and undecalcified eggshell, osteopontin was immunolocalized on the {104} crystallographic faces of calcite&mdash;its natural cleavage plane. The specific occlusion of osteopontin into calcite during mineralization may influence eggshell structure to modify its fracture resistance. <b>(J Histochem Cytochem 56:467&ndash;476, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Hincke, M. T., Chien, Y.-C., Gerstenfeld, L. C., McKee, M. D.]]></dc:creator>
<dc:date>2008-04-18</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950576</dc:identifier>
<dc:title><![CDATA[Colloidal-gold Immunocytochemical Localization of Osteopontin in Avian Eggshell Gland and Eggshell]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>476</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>467</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/5/477?rss=1">
<title><![CDATA[Glycodelin Protein and mRNA Is Downregulated in Human First Trimester Abortion and Partially Upregulated in Mole Pregnancy]]></title>
<link>http://www.jhc.org/cgi/content/short/56/5/477?rss=1</link>
<description><![CDATA[
<p>Glycodelin (Gd) is a major reproductive glycoprotein and a mediator for immunomodulatory effects directed to cellular, humoral, and innate immunity. Human pregnancy depends on a diversity of physiological processes including modulation of the maternal immunosystem. We evaluated the expression of Gd protein and mRNA in first trimester decidual tissue of normal pregnancies and spontaneous abortion and hydatidiform moles. Furthermore, in vitro experiments on endometrial cancer cells to analyze the effect of human chorionic gonadotropin (hCG) on Gd regulation were performed. In decidual tissue of abortion patients, Gd expression was significantly decreased compared with normal gestation, which was confirmed by in situ hybridization. In mole pregnancy, an upregulation of Gd in the first 8 weeks of pregnancy was present. Gd is a main product of decidual tissue in the first trimester of human pregnancy. Reduced Gd expression in abortive pregnancy could lead to an increased activation of the maternal immunosystem, thus causing rejection of the developing fetus. Moreover, Gd expression in endometrial cancer cells in vitro could be stimulated by addition of hCG. Therefore, we speculate that hCG could be one of the factors regulating Gd expression because hCG is downregulated in women with abortion and upregulated in mole pregnancy. In addition, we found a positive feedback loop in Gd and hCG expression in human pregnancy. <b>(J Histochem Cytochem 56:477&ndash;485, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Toth, B., Roth, K., Kunert-Keil, C., Scholz, C., Schulze, S., Mylonas, I., Friese, K., Jeschke, U.]]></dc:creator>
<dc:date>2008-04-18</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950600</dc:identifier>
<dc:title><![CDATA[Glycodelin Protein and mRNA Is Downregulated in Human First Trimester Abortion and Partially Upregulated in Mole Pregnancy]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>485</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>477</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/5/487?rss=1">
<title><![CDATA[Molecular Definition of High-resolution Multicolor Banding Probes: First Within the Human DNA Sequence Anchored FISH Banding Probe Set]]></title>
<link>http://www.jhc.org/cgi/content/short/56/5/487?rss=1</link>
<description><![CDATA[
<p>Fluorescence in situ hybridization (FISH) banding approaches are standard for the exact characterization of simple, complex, and even cryptic chromosomal aberrations within the human genome. The most frequently applied FISH banding technique is the multicolor banding approach, also abbreviated as m-band, MCB, or in its whole genomic variant multitude MCB (mMCB). MCB allows the differentiation of chromosome region&ndash;specific areas at the GTG band and sub-band level and is based on region-specific microdissection libraries, producing changing fluorescence intensity ratios along the chromosomes. The latter are used to assign different pseudocolors to specific chromosomal regions. Here we present the first bacterial artificial chromosome (BAC) array comparative genomic hybridization (aCGH) mapped, comprehensive, genome-wide human MCB probe set. All 169 region-specific microdissection libraries were characterized in detail for their size and the regions of overlap. In summary, the unique possibilities of the MCB technique to characterize chromosomal breakpoints in one FISH experiment are now complemented by the feature of being anchored within the human DNA sequence at the BAC level. <b>(J Histochem Cytochem 56:487&ndash;493, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Weise, A., Mrasek, K., Fickelscher, I., Claussen, U., Cheung, S. W., Cai, W. W., Liehr, T., Kosyakova, N.]]></dc:creator>
<dc:date>2008-04-18</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950550</dc:identifier>
<dc:title><![CDATA[Molecular Definition of High-resolution Multicolor Banding Probes: First Within the Human DNA Sequence Anchored FISH Banding Probe Set]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>493</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>487</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/5/495?rss=1">
<title><![CDATA[Murine mCLCA6 Is an Integral Apical Membrane Protein of Non-goblet Cell Enterocytes and Co-localizes With the Cystic Fibrosis Transmembrane Conductance Regulator]]></title>
<link>http://www.jhc.org/cgi/content/short/56/5/495?rss=1</link>
<description><![CDATA[
<p>The CLCA family of proteins consists of a growing number of structurally and functionally diverse members with distinct expression patterns in different tissues. Several CLCA homologs have been implicated in diseases with secretory dysfunctions in the respiratory and intestinal tracts. Here we present biochemical protein characterization and details on the cellular and subcellular expression pattern of the murine mCLCA6 using specific antibodies directed against the amino- and carboxy-terminal cleavage products of mCLCA6. Computational and biochemical characterizations revealed protein processing and structural elements shared with hCLCA2 including anchorage in the apical cell membrane by a transmembrane domain in the carboxy-terminal subunit. A systematic light- and electron-microscopic immunolocalization found mCLCA6 to be associated with the microvilli of non-goblet cell enterocytes in the murine small and large intestine but in no other tissues. The expression pattern was confirmed by quantitative RT-PCR following laser-capture microdissection of relevant tissues. Confocal laser scanning microscopy colocalized the mCLCA6 protein with the cystic fibrosis transmembrane conductance regulator CFTR at the apical surface of colonic crypt cells. Together with previously published functional data, the results support a direct or indirect role of mCLCA6 in transepithelial anion conductance in the mouse intestine. <b>(J Histochem Cytochem 56:495&ndash;509, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Bothe, M. K., Braun, J., Mundhenk, L., Gruber, A. D.]]></dc:creator>
<dc:date>2008-04-18</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950592</dc:identifier>
<dc:title><![CDATA[Murine mCLCA6 Is an Integral Apical Membrane Protein of Non-goblet Cell Enterocytes and Co-localizes With the Cystic Fibrosis Transmembrane Conductance Regulator]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>509</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>495</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/5/511?rss=1">
<title><![CDATA[Cannabinoid CB1 Receptors Are Expressed by Parietal Cells of the Human Gastric Mucosa]]></title>
<link>http://www.jhc.org/cgi/content/short/56/5/511?rss=1</link>
<description><![CDATA[
<p>Experimental data suggest that the endogenous cannabinoid system is involved in gastric function in different animal species. In most of them, CB<SUB>1</SUB> receptors have been localized on vagal terminals innervating the external wall of the stomach. We aimed at studying the putative presence and distribution of these receptors in the human gastric mucosa. To this end, we first performed Western blotting, RT-PCR, in situ hybridization, and immunohistochemical analysis of CB<SUB>1</SUB> protein distribution in biopsy samples of healthy individuals. To determine the precise cell populations expressing CB<SUB>1</SUB> receptors, we performed double immunofluorescence plus confocal microscopy analysis of the same samples. Our results show that CB<SUB>1</SUB> receptors are present in the gastric epithelium of the mucosa. Specifically, they are expressed by a subpopulation of mucosal cells, the acid-secreting parietal cells, as shown by double immunohistochemical staining and by their differential abundance in subregions of the gastric mucosa. These results reinforce the notion of a prominent role for the endocannabinoid system in the gastric function in humans and postulate the use of cannabinoid CB<SUB>1</SUB> receptors in parietal cells as new therapeutic targets for the regulation of gastric acid production. <b>(J Histochem Cytochem 56:511&ndash;516, 2008)</b></p>
]]></description>
<dc:creator><![CDATA[Pazos, M. R., Tolon, R. M., Benito, C., Rodriguez, C. F., Gorgojo, J. J., Nevado, M., Alvarez, M., Arias, F., Almodovar, F., Fernandez, M. T. P., Lledo, J. L., Gonzalez, S., Fernandez-Ruiz, J. J., Romero, J.]]></dc:creator>
<dc:date>2008-04-18</dc:date>
<dc:identifier>info:doi/10.1369/jhc.2008.950741</dc:identifier>
<dc:title><![CDATA[Cannabinoid CB1 Receptors Are Expressed by Parietal Cells of the Human Gastric Mucosa]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>516</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>511</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://www.jhc.org/cgi/content/short/56/5/517?rss=1">
<title><![CDATA[Pathogenic Role of NF-{kappa}B Activation in Tubulointerstitial Inflammatory Lesions in Human Lupus Nephritis]]></title>
<link>http://www.jhc.org/cgi/content/short/56/5/517?rss=1</link>
<description><![CDATA[
<p>In vitro and in vivo experimental studies suggest that the transcription factor NF-B plays a role in tubulointerstitial injury. We investigated possible cellular and molecular mechanisms involving NF-B activation in the progression of tubulointerstitial lesions in human lupus nephritis (LN). Paraffin-embedded renal biopsies from 50 patients with LN and six control patients with minimal change disease (MCD) were examined by Southwestern histochemistry for in situ detection of active NF-B and AP-1. Immunohistochemistry was performed to examine the expression of NF-B, AP-1, and NF-B regulatory proteins (IB-, p-IB-, and IKK- proteins), as well as NF-B and AP-1 downstream target proinflammatory molecules (ICAM-1, TNF-, IL-1&beta;, IL-6, and GM-CSF) and NF-B upstream signaling molecules (CD40 and CD40L). We observed extensive upregulation of activated NF-B in renal tubular cells and interstitial cells, in parallel with overactivation of transcription factor AP-1 in LN, as compared with normal controls and MCD. Tubular expression of activated NF-B correlated well with the degree of tubulointerstitial histopathological indices and/or renal function. Tubulointerstitial IKK- expression was specifically upregulated in LN. IB- and p-IB- were detected only in interstitial cells in LN. Tubulointerstitial expression levels of NF-B and AP-1 downstream inflammatory molecules and NF-B upstream signaling molecules CD40 and CD40L were markedly enhanced in LN as compared with MCD or normal controls and were associated with tubulointerstitial histopathological indices and/or renal function. The results suggest that altered IKK- expression and NF-B activation along with AP-1 overexpression may play a pathogenic role in tubulointerstitial injury in human LN mediated through a network of downstream proinflammatory molecules. <b>(J Histochem Cytochem 56:517&ndash;529, 2008)</b> </p>
]]></description>
<dc:creator><![CDATA[Zheng, L., Sinniah, R., Hsu, S. I-H.]]></dc:creator>
<dc:date>2008-04-18</dc:date>
<dc:identifier>info:doi/10.1369/jhc.7A7368.2008</dc:identifier>
<dc:title><![CDATA[Pathogenic Role of NF-{kappa}B Activation in Tubulointerstitial Inflammatory Lesions in Human Lupus Nephritis]]></dc:title>
<dc:publisher>Histochemical Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>56</prism:volume>
<prism:endingPage>529</prism:endingPage>
<prism:publicationDate>2008-05-01</prism:publicationDate>
<prism:startingPage>517</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

</rdf:RDF>